Categories: aggregated

New Study of Ketamine for Depression Disorders Gets FDA Approval, But Not Medical Marijuana

This is why the recent approval given by the FDA for a study on the use of ketamine infusion for depressive disorder has caught the eyes of many. It comes after a series of advocates have reportedly called for an increase in the available clinical data on the efficacy of ketamine for such conditions.

Jason

Share
Published by
Jason

Recent Posts

Slapwoods Honors DJ Screw With Its First Official Collaboration

Slapwoods is announcing its first-ever official collaboration with DJ Screw, the late Houston legend whose…

4 hours ago

Resistance Is Fertile: A Conversation With Logan Grendel of Focused on Infinity

It could be so easy to believe that cannabis culture is something that has been…

4 hours ago

Pink Boost Goddess in Mendocino: Discover Emerald Spirit Botanicals magical family farm

Modern cultivation techniques and spiritual practices collide with Pink Boost Goddess on our next Legendary…

4 hours ago

Housing Crisis, Fentanyl, and Dogs With ODs: The Hidden Toll of Skid Row’s Opioid Epidemic

Animal rescuers and advocacy groups say dogs living on Skid Row are suffering from neglect,…

1 day ago

Cannabis Doesn’t Distort Reality. It Shows You the Director’s Cut.

This article originally appeared in High Times’ 50th Anniversary print issue. It is an excerpt…

2 days ago

Regulated, Untamed, and Built to Last: Inside Montana Cannabis

How Montana built a legal cannabis market from a thin medical marijuana law, federal raids,…

3 days ago